16-2090293-C-T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001009944.3(PKD1):​c.12436G>A​(p.Val4146Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00378 in 1,609,992 control chromosomes in the GnomAD database, including 31 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0033 ( 3 hom., cov: 34)
Exomes 𝑓: 0.0038 ( 28 hom. )

Consequence

PKD1
NM_001009944.3 missense

Scores

7
12

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 2.77
Variant links:
Genes affected
PKD1 (HGNC:9008): (polycystin 1, transient receptor potential channel interacting) This gene encodes a member of the polycystin protein family. The encoded glycoprotein contains a large N-terminal extracellular region, multiple transmembrane domains and a cytoplasmic C-tail. It is an integral membrane protein that functions as a regulator of calcium permeable cation channels and intracellular calcium homoeostasis. It is also involved in cell-cell/matrix interactions and may modulate G-protein-coupled signal-transduction pathways. It plays a role in renal tubular development, and mutations in this gene cause autosomal dominant polycystic kidney disease type 1 (ADPKD1). ADPKD1 is characterized by the growth of fluid-filled cysts that replace normal renal tissue and result in end-stage renal failure. Splice variants encoding different isoforms have been noted for this gene. Also, six pseudogenes, closely linked in a known duplicated region on chromosome 16p, have been described. [provided by RefSeq, Oct 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.010210127).
BP6
Variant 16-2090293-C-T is Benign according to our data. Variant chr16-2090293-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 256919.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-2090293-C-T is described in Lovd as [Benign]. Variant chr16-2090293-C-T is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population mid. gnomad4_exome allele frequency = 0.00384 (5592/1457686) while in subpopulation MID AF= 0.0175 (101/5760). AF 95% confidence interval is 0.0148. There are 28 homozygotes in gnomad4_exome. There are 2963 alleles in male gnomad4_exome subpopulation. Median coverage is 34. This position pass quality control queck.
BS2
High AC in GnomAd4 at 501 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
PKD1NM_001009944.3 linkuse as main transcriptc.12436G>A p.Val4146Ile missense_variant 45/46 ENST00000262304.9 NP_001009944.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
PKD1ENST00000262304.9 linkuse as main transcriptc.12436G>A p.Val4146Ile missense_variant 45/461 NM_001009944.3 ENSP00000262304.4 P98161-1
PKD1ENST00000423118.5 linkuse as main transcriptc.12433G>A p.Val4145Ile missense_variant 45/461 ENSP00000399501.1 P98161-3
PKD1ENST00000472577.1 linkuse as main transcriptn.464G>A non_coding_transcript_exon_variant 2/32
MIR1225ENST00000408729.1 linkuse as main transcriptn.-9G>A upstream_gene_variant 6

Frequencies

GnomAD3 genomes
AF:
0.00329
AC:
501
AN:
152188
Hom.:
3
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.000651
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00164
Gnomad ASJ
AF:
0.00202
Gnomad EAS
AF:
0.000386
Gnomad SAS
AF:
0.00641
Gnomad FIN
AF:
0.00216
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00547
Gnomad OTH
AF:
0.00669
GnomAD3 exomes
AF:
0.00439
AC:
1076
AN:
244946
Hom.:
5
AF XY:
0.00484
AC XY:
645
AN XY:
133308
show subpopulations
Gnomad AFR exome
AF:
0.000504
Gnomad AMR exome
AF:
0.00291
Gnomad ASJ exome
AF:
0.00287
Gnomad EAS exome
AF:
0.000110
Gnomad SAS exome
AF:
0.00857
Gnomad FIN exome
AF:
0.00442
Gnomad NFE exome
AF:
0.00498
Gnomad OTH exome
AF:
0.00684
GnomAD4 exome
AF:
0.00384
AC:
5592
AN:
1457686
Hom.:
28
Cov.:
34
AF XY:
0.00409
AC XY:
2963
AN XY:
724654
show subpopulations
Gnomad4 AFR exome
AF:
0.000689
Gnomad4 AMR exome
AF:
0.00283
Gnomad4 ASJ exome
AF:
0.00215
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00834
Gnomad4 FIN exome
AF:
0.00527
Gnomad4 NFE exome
AF:
0.00363
Gnomad4 OTH exome
AF:
0.00448
GnomAD4 genome
AF:
0.00329
AC:
501
AN:
152306
Hom.:
3
Cov.:
34
AF XY:
0.00290
AC XY:
216
AN XY:
74472
show subpopulations
Gnomad4 AFR
AF:
0.000649
Gnomad4 AMR
AF:
0.00163
Gnomad4 ASJ
AF:
0.00202
Gnomad4 EAS
AF:
0.000386
Gnomad4 SAS
AF:
0.00642
Gnomad4 FIN
AF:
0.00216
Gnomad4 NFE
AF:
0.00547
Gnomad4 OTH
AF:
0.00662
Alfa
AF:
0.00474
Hom.:
1
Bravo
AF:
0.00276
TwinsUK
AF:
0.00216
AC:
8
ALSPAC
AF:
0.00285
AC:
11
ESP6500AA
AF:
0.000911
AC:
4
ESP6500EA
AF:
0.00431
AC:
37
ExAC
AF:
0.00470
AC:
569
Asia WGS
AF:
0.00491
AC:
17
AN:
3478
EpiCase
AF:
0.00611
EpiControl
AF:
0.00587

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenNov 01, 2024PKD1: BS2 -
Likely benign, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
Likely benign, criteria provided, single submitterclinical testingGeneDxMar 16, 2021This variant is associated with the following publications: (PMID: 22383692, 10200984, 27843768, 27499327, 27401137, 11967008, 31488014) -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
not specified Benign:2
Likely benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Polycystic kidney disease, adult type Benign:2
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesFeb 08, 2019- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsMay 23, 2017- -
Polycystic kidney disease Benign:1
Likely benign, no assertion criteria providedclinical testingDepartment of Pathology and Laboratory Medicine, Sinai Health System-The PKD1 p.Val4146Ile variant was identified in 8 of 1080 proband chromosomes (frequency: 0.007) from individuals or families with ADPKD (Badenas 1999, Rossetti 2012, Rossetti 2002, Stekrova 2009). The variant was also identified in the following databases: dbSNP (ID: rs148478410) as “With Likely benign allele”, ClinVar (1x, as likely benign by Prevention Genetics), LOVD 3.0 (1x, with unknown effect, 1x as "Probably does not affect function"), ADPKD Mutation Database (as likely neutral). The variant was not identified in the PKD1-LOVD database. The variant was identified in control databases in 1211 of 271698 (5 homozygous) chromosomes at a frequency of 0.004457 in the following populations: African in 11 of 23782 chromosomes (freq. 0.00046), other in 41 of 6358 chromosomes (freq. 0.0064), Latino in 102 of 34238 chromosomes (freq. 0.003), European in 644 of 12418 (2 homozygous) chromosomes (freq. 0.005), Ashkenazi Jewish in 30 of 9890 chromosomes (freq. 0.003), East Asian in 1 of 18826 chromosomes (freq. 0.00005), Finnish in 117 of 25656 chromosomes (freq. 0.0045), and South Asian in 265 of 30530 (3 homozygous) chromosomes (freq. 0.0086), increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Consortium Feb 27, 2017). A co-occurring pathogenic PKD1 variant (c.7864-1G>T) was identified in 1 individual with ADPKD in our laboratory, increasing the likelihood that p.Val4146Ile variant does not have clinical significance. The p.Val4146 residue is conserved in mammals but not in more distantly related organisms however four out of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and 4 of 5 in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) predict a greater than 10% difference in splicing. However, this information is not predictive enough to assume pathogenicity. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.22
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.54
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.24
T;.
Eigen
Uncertain
0.42
Eigen_PC
Uncertain
0.38
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Benign
0.84
T;T
M_CAP
Benign
0.045
D
MetaRNN
Benign
0.010
T;T
MetaSVM
Benign
-0.91
T
MutationAssessor
Uncertain
2.6
M;.
PrimateAI
Uncertain
0.55
T
PROVEAN
Benign
-0.76
N;N
REVEL
Benign
0.072
Sift
Benign
0.16
T;T
Sift4G
Uncertain
0.034
D;D
Polyphen
0.97
D;D
Vest4
0.81
MVP
0.78
ClinPred
0.018
T
GERP RS
4.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.29
gMVP
0.26

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs148478410; hg19: chr16-2140294; COSMIC: COSV99238895; COSMIC: COSV99238895; API